Boosting NAD+ Improves Mitochondrial Health Following Cerebral Ischemia
Researchers from the University of Maryland and the Veterans Affairs Maryland Health Center recently found that NMN improves mitochondrial NAD+ metabolism and mitochondrial health via SIRT3 in ischemic mice.
Molecular Model of Restoration of Cognition in Aging
Scientists from Washington University School of Medicine in St. Louis, Missouri obtain data from a study to propose a model of age-related cognitive decline. According to the model, nicotinamide mononucleotide (NMN) consumption improves symptoms associated with age-related cognitive decline in mice.
NAD+ Alleviating Symptoms of Alzheimer’s Disease in Mice
Recent research on Alzheimers Disease from the Shanghai Geriatric Institute of Chinese Medicine and Shanghai University of Traditional Chinese Medicine identified Nicotinamide Mononucleotide (NMN) synthesis as a principal step in disease progression.
A Therapeutic Approach to Falling NAD+ Levels After Brain Injury
Scientists elaborate how NAD+ depletion compromises the ability of mitochondria to counteract free radical and reactive oxygen species buildup.
Rescuing Lifespan of Leigh Syndrome Mice with NAD+ Regeneration
Nicotinamide adenine dinucleotide (NAD+) regeneration salvages lifespan but not movement and balance problems in mice with brain mitochondrial dysfunction.
Neuroprotective Chemicals Prevent Neurodegeneration and Preserve Function After Traumatic Brain Inju
Scientists hope that neuroprotective chemicals called P7C3 will become new interventions for nerve cell dysfunction that currently lack treatment options